RAC 0.97% $1.54 race oncology ltd

Ann: Race investor briefing invitation, page-28

  1. 82 Posts.
    lightbulb Created with Sketch. 6
    On the very first point, Dr T has stated we found out the drug wasn't lost, the old owners decided to focus more on another drug and bisantrene was never followed up on. It was a cost thing if I remember correctly.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.